Assessment
Questionnaire
Have a symptom?
See what questions
a doctor would ask.
Clinical Trials for Adenocarcinoma, Clear Cell
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Adenocarcinoma, Clear Cell is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Adenocarcinoma, Clear Cell:
- Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin
- Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer - This study has been completed (Current: 23 Nov 2006) - paclitaxel
- Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,paclitaxel
- Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - thalidomide
- Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,paclitaxel
- Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin,filgrastim,paclitaxel,pegfilgrastim
- Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interleukin-2
- RPI.4610 in Treating Patients With Metastatic Kidney Cancer - This study has been completed (Current: 23 Nov 2006) - RPI.4610
- Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - allogeneic lymphocytes,fludarabine,mycophenolate mofetil,tacrolimus,thalidomide
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - allogeneic lymphocytes,cyclophosphamide,filgrastim,fludarabine,methotrexate,tacrolimus
- Epothilone B in Treating Patients With Advanced Kidney Cancer - This study has been completed (Current: 23 Nov 2006) - epothilone B
- Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
- Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) - This study is no longer recruiting patients (Current: 23 Nov 2006) - bevacizumab,interferon alfa
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer - This study has been completed (Current: 23 Nov 2006) - 17-N-allylamino-17-demethoxygeldanamycin
- Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa,sorafenib
- CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study has been suspended (Current: 23 Nov 2006) - bevacizumab,temsirolimus
- Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - ixabepilone
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - cyclosporine,fludarabine,mycophenolate mofetil
- Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - aldesleukin,genistein
- Immunochemotherapy for Metastatic Renal Cell Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Capecitabine (Xeloda)
- A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers - This study has been suspended (Current: 23 Nov 2006) - Celecoxib
- Gene Therapy in Treating Patients With Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin hydrochloride,epirubicin hydrochloride
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - cisplatin,doxorubicin hydrochloride
- Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - cisplatin,paclitaxel
- Genetic Study of Patients With Inherited Urologic Malignancies - This study is currently recruiting patients (Current: 23 Nov 2006)
- Total-Body Irradiation and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Kidney Cancer - This study has been completed (Current: 23 Nov 2006) - allogeneic lymphocytes,cyclosporine,fludarabine,mycophenolate mofetil
- Ixabepilone in Treating Patients With Renal Cell Carcinoma (Kidney Cancer) - This study is currently recruiting patients (Current: 23 Nov 2006) - ixabepilone
- CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - temsirolimus
- Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - cyclosporine,fludarabine,mycophenolate mofetil
- Monoclonal Antibody Therapy (Rencarex) in Treating Patients Who Have Undergone Surgery for Non-Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - monoclonal antibody G250
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - HLA-A2, A3-restricted FGF-5 peptides/Montanide ISA-51 vaccine,aldesleukin
- Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - interferon alfa,sorafenib
- Tretinoin and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - aldesleukin,tretinoin
- RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma - This study is currently recruiting patients (Current: 23 Nov 2006) - monoclonal antibody RAV12
- Sorafenib and Bevacizumab in Treating Patients With Advanced Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,sorafenib
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - interferon alfa,sorafenib
- Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - sorafenib
- ATN-161 in Advanced Renal Cell Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - ATN-161
- Interferon Alfa in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - interferon alpha-1b
- Denileukin Diftitox and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - aldesleukin,denileukin diftitox
- Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - tinzaparin sodium
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - aldesleukin,bevacizumab
- AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - AZD2171
- Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - autologous dendritic cell-autologous tumor mRNA-human CD40L vaccine,therapeutic autologous dendritic cells
- Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - bevacizumab,vorinostat
- Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - sorafenib,sunitinib malate
- Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - everolimus,imatinib mesylate
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - carboplatin,cyclophosphamide,dactinomycin,doxorubicin hydrochloride,etoposide,filgrastim,irinotecan hydrochloride,vincristine
- VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - VEGF Trap
- Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - bevacizumab,sorafenib tosylate,temsirolimus
- Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - gemcitabine hydrochloride,irinotecan hydrochloride
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Adenocarcinoma, Clear Cell:
- 17-N-allylamino-17-demethoxygeldanamycin - 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- ATN-161 - ATN-161 in Advanced Renal Cell Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- AZD2171 - AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Aldesleukin - Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Aldesleukin - Denileukin Diftitox and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Aldesleukin - Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Aldesleukin - Tretinoin and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Aldesleukin - Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Allogeneic Lymphocytes - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Allogeneic Lymphocytes - Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Allogeneic Lymphocytes - Total-Body Irradiation and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- Amifostine - Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody - Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Autologous Dendritic Cell-Autologous Tumor Mrna-Human Cd40L Vaccine - Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Bevacizumab - Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Bevacizumab - Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Bevacizumab - CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study has been suspended (Current: 23 Nov 2006)
- Bevacizumab - Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Bevacizumab - Sorafenib and Bevacizumab in Treating Patients With Advanced Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Bevacizumab - Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Capecitabine (Xeloda) - Immunochemotherapy for Metastatic Renal Cell Carcinoma - This study is currently recruiting patients (Current: 23 Nov 2006)
- Carboplatin - Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Carboplatin - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Celecoxib - A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers - This study has been suspended (Current: 23 Nov 2006)
- Cisplatin - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Cisplatin - Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Cyclophosphamide - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Cyclophosphamide - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Cyclosporine - Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
- Cyclosporine - Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Cyclosporine - Total-Body Irradiation and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- Dactinomycin - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Denileukin Diftitox - Denileukin Diftitox and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxorubicin Hydrochloride - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxorubicin Hydrochloride - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxorubicin Hydrochloride - Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxorubicin - Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Doxorubicin - Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Epirubicin Hydrochloride - Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Epothilone B - Epothilone B in Treating Patients With Advanced Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- Etoposide - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Everolimus - Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Filgrastim - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Filgrastim - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Filgrastim - Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Fludarabine - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Fludarabine - Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
- Fludarabine - Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Fludarabine - Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Fludarabine - Total-Body Irradiation and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- Gemcitabine Hydrochloride - Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Genistein - Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- HLA-A2, A3-restricted FGF-5 peptides/Montanide ISA-51 vaccine - Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Imatinib Mesylate - Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Interferon Alfa - Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Interferon Alfa - Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Interferon Alfa - Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Interferon Alfa - Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Interferon Alpha-1B - Interferon Alfa in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Interleukin-2 - Interleukin-2 in Treating Patients With Metastatic Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Irinotecan Hydrochloride - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Irinotecan Hydrochloride - Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Ixabepilone - Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Ixabepilone - Ixabepilone in Treating Patients With Renal Cell Carcinoma (Kidney Cancer) - This study is currently recruiting patients (Current: 23 Nov 2006)
- Methotrexate - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Monoclonal Antibody G250 - Monoclonal Antibody Therapy (Rencarex) in Treating Patients Who Have Undergone Surgery for Non-Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Monoclonal Antibody Rav12 - RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma - This study is currently recruiting patients (Current: 23 Nov 2006)
- Mycophenolate Mofetil - Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
- Mycophenolate Mofetil - Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Mycophenolate Mofetil - Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Mycophenolate Mofetil - Total-Body Irradiation and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- Paclitaxel - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Paclitaxel - Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Paclitaxel - Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Paclitaxel - Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Paclitaxel - Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer - This study has been completed (Current: 23 Nov 2006)
- Pegfilgrastim - Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- RPI.4610 - RPI.4610 in Treating Patients With Metastatic Kidney Cancer - This study has been completed (Current: 23 Nov 2006)
- Sorafenib Tosylate - Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Sorafenib - Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Sorafenib - Sorafenib and Bevacizumab in Treating Patients With Advanced Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Sorafenib - Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Sorafenib - Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Sorafenib - Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Sorafenib - Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
- Sunitinib Malate - Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
- Tacrolimus - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Tacrolimus - Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Temsirolimus - Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Temsirolimus - CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study has been suspended (Current: 23 Nov 2006)
- Temsirolimus - CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Thalidomide - Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Thalidomide - Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006)
- Therapeutic Autologous Dendritic Cells - Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- Tinzaparin Sodium - Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
- Tretinoin - Tretinoin and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
- VEGF Trap - VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
- Vincristine - Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors - This study is currently recruiting patients (Current: 23 Nov 2006)
- Vorinostat - Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer - This study is currently recruiting patients (Current: 23 Nov 2006)
The trial data on this page has been sourced from
» Next page:
Adenocarcinoma, Follicular
Medical Tools & Articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: